Sarah Bos

84 CHAPTER 5 96. Spiess BD. Transfusion of blood products affects outcome in cardiac surgery. Semin Cardiothorac Vasc Anesth. 2004 Dec;8(4):267–81. 97. Jia Q, Brown MJ, Clifford L, Wilson GA, Truty MJ, Stubbs JR, et al. Prophylactic plasma transfusion for surgical patients with abnormal preoperative coagulation tests: a single- institution propensity-adjusted cohort study. Lancet Haematol. 2016 Mar;3(3):e139–48. 98. Miyamoto S, Polak WG, Geuken E, Peeters PMJG, Jong KP, Porte RJ, et al. Liver transplantationwithpreservationof the inferior vena cava. A comparisonof conventional and piggyback techniques in adults. Clin Transplant. 2004 Dec;18(6):686–93. 99. Jovine E, Mazziotti A, Grazi GL, Ercolani G, Masetti M, Morganti M, et al. Piggy-back versus conventional technique in liver transplantation: Report of a randomized trial. Vol. 10, Transplant International. 1997. p. 109–12. 100. Porte RJ, Molenaar IQ, Begliomini B, Groenland TH, Januszkiewicz A, Lindgren L, et al. Aprotinin and transfusion requirements in orthotopic liver transplantation: a multicentre randomised double-blind study. EMSALT Study Group. Lancet. 2000 Apr 15;355(9212):1303–9. 101. Findlay JY, Rettke SR, Ereth MH, Plevak DJ, Krom RAF, Kufner RP. Aprotinin reduces red blood cell transfusion in orthotopic liver transplantation: A prospective, randomized, double-blind study. Liver Transplant. 2001 Sep;7(9):802–7. 102. Dalmau A, Sabate A, Koo M, Bartolome C, Rafecas A, Figueras J, et al. The prophylactic use of tranexamic acid and aprotinin in orthotopic liver transplantation: a comparative study. Vol. 10, Liver Transpl. 2004. p. 279–84. 103. Ejaz A, Spolverato G, Kim Y, Lucas DL, Lau B, Weiss M, et al. Defining Incidence and Risk Factors of Venous Thromboemolism after Hepatectomy. J Gastrointest Surg. 2014 Jun 13;18(6):1116–24. 104. Weiss MJ, Kim Y, Ejaz A, Spolverato G, Haut ER, Hirose K, et al. Venous thromboembolic prophylaxis after a hepatic resection: Patterns of care among liver surgeons. Vol. 16, Hpb. 2014. p. 892–8. 105. Aloia TA, Geerts WH, Clary BM, Day RW, Hemming AW, D’Albuquerque LC, et al. Venous Thromboembolism Prophylaxis in Liver Surgery. J Gastrointest Surg. 2016 Jan 21;20(1):221–9. 106. Yamashita Y-I, Bekki Y, Imai D, Ikegami T, Yoshizumi T, Ikeda T, et al. Efficacy of postoperative anticoagulation therapy with enoxaparin for portal vein thrombosis after hepatic resection in patients with liver cancer. Thromb Res. 2014;134(4):826–31. 107. Tiao GM, Alonso M, Bezerra J, Yazigi N, Heubi J, Balistreri W, et al. Liver transplantation in children younger than 1 year-the Cincinnati experience. J Pediatr Surg. 2005;40(1):268–73. 108. Zhao J-C, Lu S-C, Yan L-N, Li B, Wen T-F, Zeng Y, et al. Incidence and treatment of hepatic artery complications after orthotopic liver transplantation. World J Gastroenterol. 2003;9(12):2853–5. 109. Silva MA, Jambulingam PS, Gunson BK, Mayer D, Buckels JAC, Mirza DF, et al. Hepatic artery thrombosis following orthotopic liver transplantation: A 10-year experience from a single centre in the United Kingdom. Liver Transplant. 2006 Jan;12(1):146–51. 110. Madalosso C, de Souza NF, Ilstrup DM, Wiesner RH, Krom RA. Cytomegalovirus and its association with hepatic artery thrombosis after liver transplantation. Transplantation. 1998 Aug 15;66(3):294–7.